Malignant nodular hidradenoma of the skin: Report of seven cases

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 5, 2008, Pages 549-554

  Souvatzidis, P ^a   Sbano, P ^b,c   Mandato, F ^b   Fimiani, M ^b   Castelli, A ^a  

^a San Donato Hospital of Arezzo

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Clear cell hidradenoma; Hidradenocarcinoma; Malignant hidradenoma; Treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISTANT METASTASIS; FEMALE; HIDRADENOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ITALY; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RECURRENCE RISK; SEX DIFFERENCE; SURVIVAL TIME; TUMOR VOLUME; UNIVERSITY HOSPITAL;

ADENOMA, SWEAT GLAND; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SKIN; SKIN NEOPLASMS; SWEAT GLAND NEOPLASMS;

EID: 42149157687     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02504.x     Document Type: Article

References (29)

1. Keasby LE, Hadley GG. Clear cell hidradenoma: Report of three cases with widespread metastases. Cancer 1954; 7: 934-952.
2. Mehregan AH, Hashimoto J, Rahbari H. Eccrine adenocarcinoma: A clinicopathologic study of 35 cases. Arch Dermatol 1983; 119: 104-114.
3. Ohta M, Hiramoto M, Fujii M, Togo T. Nodular hidradenocarcinoma on the scalp of a young woman. case report and review of literature. Dermatol Surg 2004; 30: 1265-1268.
4. Berg JW, McDivitt RW. Pathology of Sweat Gland Carcinomas. In: Sommers SL, ed. Pathol Annual, Vol. 3. Appelton-Century-Crofts, New York, 1968: 123-144.
5. Stout AP, Cooley SGE. Carcinoma of sweat glands. Cancer 1951; 4: 521-536.
6. Wick MR, Goellner JR, Wolfe JT, Daniel Su WP. Adnexal carcinomas of the skin. Cancer 1985; 56: 1147-1162.
7. Wong T-Y, Suster S, Nogita T, Duncan LM, Dickershin RG, Mihm MC Jr. Clear cell eccrine carcinomas of the skin: A clinicopathologic study of nine patients. Cancer 1994; 73: 1631-1643.
8. Obaidat NA, Alsaad KO, Ghazarian D. Skin adnexal neoplasm. J Clin Pathol 2007; 60: 145-159.
9. Faulhaber D, Worle B, Trautner B, Sander CA. Clear cell hidradenoma in a young girl. J Am Acad Dermatol 2000; 42: 693-695.
10. Orlandi RR, Sercarz JA, Doberneck SA, Calcaterra TC. Malignant clear cell hidradenoma of the upper lip. Head Neck 1994; 16: 443-449.
11. Crowson AN, Magro CM, Mihm MC. Malignant adnexal neoplasm. Mod Pathol 2006; 19: S93-S126.
12. Biddlestone LR, McLaren KM, Tidman MJ. Malignant hidradenoma: A case report demonstrating insidious histological and clinical progression. Clin Exp Dermatol 1991; 16: 474-477.
13. Touma D, Laporte M, Goossens A, Ledoux M. Malignant clear cell hidradenoma. Dermatology 1993; 186: 284-286.
14. Khalil HM, Yusuf H, Kaddour HS. Malignant eccrine hidradenoma of neck causing acute heart failure. Auris Nasus Larynx 2003; 30: 307-310.
15. Ko CJ, Cochran AJ, Eng W, Blinder SW. Hidradenocarcinoma: A histological and immunohistochemical study. J Cutan Pathol 2006; 33: 726-730.
16. Busam KJ, Tan LK, Grantler SR. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol 1999; 12: 786-793.
17. Toulemonde A, Croue A, Rodien P, Verret JL. Malignant nodular hidradenoma and multiple nodular hidradenomas in a hypogonadic patient. Ann Dermatol Venereol 2006; 133: 1005-1008.
18. Stratigos AJ, Olbricht S, Kwan TH, Bowers KE. Nodular hidradenoma. A report of three cases and review of the literature. Dermatol Surg 1998; 24: 387-391.
19. Liapakis IE, Korkolios DP, Koutsoumbi A, Fida A, Kokkalis G. Malignant hidradenoma: A report of two cases and review of the literature. Anticancer Res 2006; 26: 2217-2220.
20. Nash JV, Barrett TL, Kies M, Ross MI, Sneige N. Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: Potential treatment implication. J Cutan Pathol 2007; 34: 49-54.
21. Gortler I, Koppl H, Stark GB, Horch RE. Metastatic malignant acrospiroma of the hand. Eur J Surg Oncol 2001; 27: 431-435.
22. Harari PM, Shimm DS, Bangert JL, Cassady JR. The role of radiotherapy in the treatment of malignant sweat gland neoplasms. Cancer 1990; 65: 1737-1740.
23. Hernandez-Perez E, Cestoni-Parducci R. Nodular hidradenoma and hidradenocarcinoma. J Am Acad Dermatol 1985; 12: 15-20.
24. Long WP, Dupin C, Levine EA. Recurrent malignant acrospiroma. Dermatol Surg 1998; 24: 908-912.
25. Messing MJ, Richardson MS, Smith MT, King L, Gallup DG. Metastatic clear cell hidradenocarcinoma of the vulva. Gynecol Oncol 1993; 48: 264-268.
26. Jouary T, Kaiafa A, Lipinski P, Vergier B, Lepreux S. Metastatic hidradenocarcinoma: Efficacy of capecitabine. Arch Dermatol 2006; 142: 1366-1367.
27. Tolland JP, Brenn T, Guldbakke KK, Schanbacher CF. Mohs micrographic surgery sentinel lymph node mapping, and estrogen receptor analysis for the treatment of malignant nodular hidradenoma. Dermatol Surg 2006; 32: 1294-1301.
28. House NS, Helm KF, Maloney ME. Management of a hidradenoma with Mohs micrographic surgery. J Dermatol Surg Oncol 1994; 20: 619-622.
29. Ashley I, Smith-Reed M, Chernys A. Sweat gland carcinoma: Case report and review of the literature. Dermatol Surg 1997; 23: 129-133.